Early research (Phase 1)Ended earlyNCT02689726
What this trial is testing
Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL
Who this might be right for
HPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL
Genticel 13